Paper12840783
New molecular mechanism for Ullrich congenital muscular dystrophy: a heterozygous in-frame deletion in the COL6A1 gene causes a severe phenotype.
Pan TC and 5 others. Am J Hum Genet, 2003. Cited by 124 papers, by iCite.
Cite this record
ConductScience Library. New molecular mechanism for Ullrich congenital muscular dystrophy: a heterozygous in-frame deletion in the COL6A1 gene causes a severe phenotype. Papers, record 12840783. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12840783
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics23
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Collagen Type VI | Major topic |
| Muscular Dystrophies | Major topic |
| Amino Acid Sequence | |
| Base Sequence | |
| Child | |
| DNA, Complementary | |
| Dimerization | |
| Exons | |
| Extracellular Matrix | |
| Fibroblasts | |
| Genes, Dominant | |
| Genotype | |
| Heterozygote | |
| Humans | |
| Introns | |
| Male | |
| Molecular Sequence Data | |
| Muscles | |
| Phenotype | |
| Protein Structure, Tertiary | |
| RNA, Messenger | |
| Sequence Deletion | |
| Sequence Homology, Nucleic Acid |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 AR038912 | NIAMS NIH HHS | United States | R01AR038912 | PubMed and NIH |
| AR38912 | NIAMS NIH HHS | United States | R01AR038912 | PubMed and NIH |
Source NIH RePORTER
References40
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12374585 | Collagen type VI and related disorders: Bethlem myopathy and Ullrich scleroatonic muscular dystrophy. | Eur J Paediatr Neurol | 2002 | https://conductscience.org/library/papers/12374585 | PubMed |
| 2 | 12297580 | Ullrich disease: collagen VI deficiency: EM suggests a new basis for muscular weakness. | Neurology | 2002 | https://conductscience.org/library/papers/12297580 | PubMed |
| 3 | 12424008 | Defective glycosylation in muscular dystrophy. | Lancet | 2002 | https://conductscience.org/library/papers/12424008 | PubMed |
| 4 | 12218063 | Effects on collagen VI mRNA stability and microfibrillar assembly of three COL6A2 mutations in two families with Ullrich congenital muscular dystrophy. | J Biol Chem | 2002 | https://conductscience.org/library/papers/12218063 | PubMed |
| 5 | 963533 | Benign myopathy, with autosomal dominant inheritance. A report on three pedigrees. | Brain | 1976 | https://conductscience.org/library/papers/963533 | PubMed |
| 6 | 3198591 | Amino acid sequence of the triple-helical domain of human collagen type VI. | J Biol Chem | 1988 | https://conductscience.org/library/papers/3198591 | PubMed |
| 7 | 2651568 | Ullrich's congenital atonic sclerotic muscular dystrophy. A case report. | J Neurol | 1989 | https://conductscience.org/library/papers/2651568 | PubMed |
| 8 | 2551668 | Sequence analysis of alpha 1(VI) and alpha 2(VI) chains of human type VI collagen reveals internal triplication of globular domains similar to the A domains of von Willebrand factor and two alpha 2(VI) chain variants that differ in the carboxy terminus. | EMBO J | 1989 | https://conductscience.org/library/papers/2551668 | PubMed |
| 9 | 1689238 | Mosaic structure of globular domains in the human type VI collagen alpha 3 chain: similarity to von Willebrand factor, fibronectin, actin, salivary proteins and aprotinin type protease inhibitors. | EMBO J | 1990 | https://conductscience.org/library/papers/1689238 | PubMed |
| 10 | 2203776 | Mutations that alter the primary structure of type I collagen. The perils of a system for generating large structures by the principle of nucleated growth. | J Biol Chem | 1990 | https://conductscience.org/library/papers/2203776 | PubMed |
| 11 | 1867713 | The zipper-like folding of collagen triple helices and the effects of mutations that disrupt the zipper. | Annu Rev Biophys Biophys Chem | 1991 | https://conductscience.org/library/papers/1867713 | PubMed |
| 12 | 1425570 | Structure of recombinant N-terminal globule of type VI collagen alpha 3 chain and its binding to heparin and hyaluronan. | EMBO J | 1992 | https://conductscience.org/library/papers/1425570 | PubMed |
| 13 | 8168508 | Recombinant expression and structural and binding properties of alpha 1(VI) and alpha 2(VI) chains of human collagen type VI. | Eur J Biochem | 1994 | https://conductscience.org/library/papers/8168508 | PubMed |
| 14 | 7773292 | The minisatellite in the diabetes susceptibility locus IDDM2 regulates insulin transcription. | Nat Genet | 1995 | https://conductscience.org/library/papers/7773292 | PubMed |
| 15 | 7596809 | Characterisation of a novel minisatellite that provides multiple splice donor sites in an interferon-induced transcript. | Nucleic Acids Res | 1995 | https://conductscience.org/library/papers/7596809 | PubMed |
| 16 | 8575781 | Head to tail organization of the human COL6A1 and COL6A2 genes by fiber-FISH. | Genomics | 1995 | https://conductscience.org/library/papers/8575781 | PubMed |
| 17 | 8782832 | Type VI collagen mutations in Bethlem myopathy, an autosomal dominant myopathy with contractures. | Nat Genet | 1996 | https://conductscience.org/library/papers/8782832 | PubMed |
| 18 | 9334230 | Type VI collagen anchors endothelial basement membranes by interacting with type IV collagen. | J Biol Chem | 1997 | https://conductscience.org/library/papers/9334230 | PubMed |
| 19 | 9468540 | Structurally abnormal type II collagen in a severe form of Kniest dysplasia caused by an exon 24 skipping mutation. | J Biol Chem | 1998 | https://conductscience.org/library/papers/9468540 | PubMed |
| 20 | 9516440 | The role of the alpha3(VI) chain in collagen VI assembly. Expression of an alpha3(VI) chain lacking N-terminal modules N10-N7 restores collagen VI assembly, secretion, and matrix deposition in an alpha3(VI)-deficient cell line. | J Biol Chem | 1998 | https://conductscience.org/library/papers/9516440 | PubMed |
Cited by57
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 124 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41439068 | Diagnostic Precision in Pediatric Neuromuscular Disorders: A Case Study of Bethlem Myopathy Mimicking Duchenne Muscular Dystrophy. | Cureus | 2025 | https://conductscience.org/library/papers/41439068 | PubMed |
| 40225172 | The UCMD-Causing COL6A1 (c.930 + 189C > T) Intron Mutation Leads to the Secretion and Aggregation of Single Mutated Collagen VI α1 Chains. | Hum Mutat | 2023 | https://conductscience.org/library/papers/40225172 | PubMed |
| 40177858 | Characterization of severe COL6-related dystrophy due to the recurrent variant COL6A1 c.930+189C>T. | Brain | 2025 | https://conductscience.org/library/papers/40177858 | PubMed |
| 39595588 | Restored Collagen VI Microfilaments Network in the Extracellular Matrix of CRISPR-Edited Ullrich Congenital Muscular Dystrophy Fibroblasts. | Biomolecules | 2024 | https://conductscience.org/library/papers/39595588 | PubMed |
| 38937821 | The double whammy of ER-retention and dominant-negative effects in numerous autosomal dominant diseases: significance in disease mechanisms and therapy. | J Biomed Sci | 2024 | https://conductscience.org/library/papers/38937821 | PubMed |
| 38617974 | Optimized allele-specific silencing of the dominant-negative COL6A1 G293R substitution causing collagen VI-related dystrophy. | Mol Ther Nucleic Acids | 2024 | https://conductscience.org/library/papers/38617974 | PubMed |
| 38585825 | The recurrent deep intronic pseudoexon-inducing variant COL6A1 c.930+189C>T results in a consistently severe phenotype of COL6-related dystrophy: Towards clinical trial readiness for splice-modulating therapy. | medRxiv | 2024 | https://conductscience.org/library/papers/38585825 | PubMed |
| 37686358 | Features of Congenital Arthrogryposis Due to Abnormalities in Collagen Homeostasis, a Scoping Review. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37686358 | PubMed |
| 37569848 | New Clinical and Immunofluoresence Data of Collagen VI-Related Myopathy: A Single Center Cohort of 69 Patients. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37569848 | PubMed |
| 36982167 | Collagen VI in the Musculoskeletal System. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36982167 | PubMed |
| 35832501 | Autosomal dominant Ullrich congenital muscular dystrophy due to a de novo mutation in COL6A3 gene. A case report. | Acta Myol | 2022 | https://conductscience.org/library/papers/35832501 | PubMed |
| 34729958 | Transcriptome analysis of collagen VI-related muscular dystrophy muscle biopsies. | Ann Clin Transl Neurol | 2021 | https://conductscience.org/library/papers/34729958 | PubMed |
| 34167565 | Causative variant profile of collagen VI-related dystrophy in Japan. | Orphanet J Rare Dis | 2021 | https://conductscience.org/library/papers/34167565 | PubMed |
| 33250842 | Clinical and Genomic Evaluation of 207 Genetic Myopathies in the Indian Subcontinent. | Front Neurol | 2020 | https://conductscience.org/library/papers/33250842 | PubMed |
| 32585628 | Exon-Skipping Oligonucleotides Restore Functional Collagen VI by Correcting a Common COL6A1 Mutation in Ullrich CMD. | Mol Ther Nucleic Acids | 2020 | https://conductscience.org/library/papers/32585628 | PubMed |
| 31387942 | Basement membrane collagens and disease mechanisms. | Essays Biochem | 2019 | https://conductscience.org/library/papers/31387942 | PubMed |
| 30895940 | A recurrent COL6A1 pseudoexon insertion causes muscular dystrophy and is effectively targeted by splice-correction therapies. | JCI Insight | 2019 | https://conductscience.org/library/papers/30895940 | PubMed |
| 30174616 | Extracellular Collagen VI Has Prosurvival and Autophagy Instructive Properties in Mouse Fibroblasts. | Front Physiol | 2018 | https://conductscience.org/library/papers/30174616 | PubMed |
| 29067961 | Genetic and Clinical Advances of Congenital Muscular Dystrophy. | Chin Med J (Engl) | 2017 | https://conductscience.org/library/papers/29067961 | PubMed |
| 28831785 | Clinical, Pathologic, and Genetic Features of Collagen VI-Related Myopathy in Korea. | J Clin Neurol | 2017 | https://conductscience.org/library/papers/28831785 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| COL6A1 | 1291 | PubTator's text mining | https://conductscience.org/library/genes/1291 | NCBI Gene |
| COL6A2 | 1292 | PubTator's text mining | https://conductscience.org/library/genes/1292 | NCBI Gene |
| COL6A3 | 1293 | PubTator's text mining | https://conductscience.org/library/genes/1293 | NCBI Gene |
Data4
The data bank entries PubMed's record names. Trial numbers are under Trials.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/12840783
GET https://conductscience.org/api/papers/v1/12840783/references?page=2